Virax Biolabs Stock Faces a Make-or-Break Nasdaq Vote After a Wild Week
Virax closed Friday at $0.2775, down 9.31%, but up 81% from May 15. Shareholders will vote June 5 on a 10-for-1 to 30-for-1 reverse share consolidation as the company faces a July 11 Nasdaq deadline to regain $1 minimum bid compliance. U.S. markets are closed Monday for Memorial Day, with trading to resume Tuesday. Armistice Capital disclosed a 4.99% stake in Virax earlier this month.